Pancreatic Hormone Analysis – Insulin, Glucagon & C-Peptide
Pancreatic hormone analysis is a laboratory test that measures hormones produced by the pancreas, such as insulin, glucagon, and C-peptide. It is used to diagnose metabolic disorders including diabetes mellitus.
Things worth knowing about "Pancreatic Hormone Analysis"
Pancreatic hormone analysis is a laboratory test that measures hormones produced by the pancreas, such as insulin, glucagon, and C-peptide. It is used to diagnose metabolic disorders including diabetes mellitus.
What is Pancreatic Hormone Analysis?
Pancreatic hormone analysis is a diagnostic laboratory procedure that measures the concentration of hormones produced by the pancreas. The pancreas is a vital gland that serves two main functions: it produces digestive enzymes (exocrine function) and secretes essential hormones (endocrine function). The hormone-producing cells are located in specialized clusters known as the islets of Langerhans.
The hormones analyzed play a central role in regulating blood glucose levels and energy metabolism. By measuring these hormones, clinicians can gain important insights into pancreatic function and identify potential disorders.
Which Hormones Are Analyzed?
A pancreatic hormone analysis may include measurement of the following hormones:
- Insulin: Produced by beta cells in the islets of Langerhans, insulin lowers blood glucose by facilitating the uptake of glucose into body cells.
- Glucagon: Produced by alpha cells, glucagon raises blood glucose levels by stimulating the liver to release stored glucose.
- C-peptide: A byproduct of insulin production that reflects the body's own insulin synthesis. It is frequently used to distinguish between type 1 and type 2 diabetes.
- Somatostatin: Produced by delta cells, somatostatin inhibits the release of both insulin and glucagon and slows gastric emptying.
- Pancreatic Polypeptide (PP): Regulates the secretion of digestive enzymes and influences appetite control.
When is Pancreatic Hormone Analysis Used?
This diagnostic test is ordered in a variety of clinical situations, including:
- Suspected type 1 or type 2 diabetes mellitus
- Investigation of hypoglycemia (abnormally low blood sugar), particularly in cases of unexplained dizziness or loss of consciousness
- Suspected insulinoma (a benign insulin-secreting tumor of the pancreas)
- Follow-up after pancreatic surgery or transplantation
- Assessment of neuroendocrine tumors of the pancreas
- Evaluation of insulin resistance in the context of metabolic syndrome
- Monitoring of insulin therapy in patients with diabetes
How is the Test Performed?
Pancreatic hormone analysis is typically performed through a simple blood draw from a vein, usually in the arm. Depending on the clinical question, specific conditions may be required:
- Fasting blood draw: For fasting insulin or glucagon measurements, the patient should not eat for at least 8 hours prior to the sample collection.
- Stimulation tests: To specifically assess insulin secretion, an oral glucose tolerance test (oGTT) may be performed, in which multiple blood samples are taken after ingestion of a defined amount of glucose.
- Fasting test: When an insulinoma is suspected, a supervised 72-hour fasting test may be conducted in a hospital setting, with regular measurements of insulin, C-peptide, and blood glucose.
Reference Values and Interpretation
Reference values may vary slightly depending on the laboratory and the analytical method used. Typical fasting reference ranges for adults include:
- Fasting insulin: 2.6 – 24.9 mIU/L (may vary by laboratory)
- Fasting glucagon: 20 – 100 pg/mL
- C-peptide (fasting): 0.5 – 2.0 nmol/L
Elevated insulin levels may indicate an insulinoma, insulin resistance, or type 2 diabetes. Low C-peptide levels suggest type 1 diabetes with destruction of beta cells, while normal or elevated C-peptide levels are more consistent with type 2 diabetes or an insulinoma.
Clinical Significance
Pancreatic hormone analysis is an indispensable tool in modern medicine. It enables:
- Accurate differentiation between types of diabetes
- Detection of rare tumors such as insulinoma or glucagonoma
- Assessment of residual pancreatic function following surgical procedures
- Guidance of insulin therapy in insulin-dependent patients
- Early detection of metabolic disorders during routine health screenings
References
- World Health Organization (WHO): Classification of Diabetes Mellitus. Geneva: WHO, 2019. Available at: www.who.int
- American Diabetes Association (ADA): Standards of Medical Care in Diabetes 2023. Diabetes Care, 46(Suppl. 1), 2023.
- Melmed, S. et al.: Williams Textbook of Endocrinology, 14th edition. Philadelphia: Elsevier, 2020.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMacronutrients
Food craving
Portion control
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Pancreatic Hormone Analysis-en